All the latest packaging trends for life sciences, all at PACK EXPO East
Explore new packaging solutions for life sciences, all in one convenient location at PACK EXPO East, March 18 – 20 in Philadelphia.

FDA Approves Activ-Blister™ Packaging for HIV Drug

The FDA has approved AptarGroup’s packaging solution for oral solid dose HIV prevention medicine.

Activ-Blister Packaging / Image: Aptar
Activ-Blister Packaging / Image: Aptar

A recent Valdosta Daily Times article noted the approval of a new drug packaging solution intended for oral solid does HIV prevention medicine. The FDA gave the green light to AptarGroup’s Activ-Blister™ packaging that uses silica gel and molecular sieve technology to absorb tailored amounts of water vapor, oxygen, or a combination of the two. It can also scavenge odors and volatile organic compounds.

“I am very pleased to announce this recent FDA approval of our proprietary Activ-Blister ™ technology,” said Stephan Tanda, Aptar’s President and CEO. “This is a significant step that further validates the expanding portfolio of solutions offered by Aptar CSP Technologies. We will continue to leverage our proprietary 3-Phase Activ-Polymer ™ technology to help our customers with unique protective formulations that derisk their drug development process and help strengthen their own offerings. The ultimate result is that we are creating meaningful solutions that help improve and save lives.”

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader